Health Care Stocks Mixed to Lower in Late Trading

Health care stocks are experiencing a mixed bag as the day comes to a close, with some notable updates in the sector. Sanofi-Aventis is considering raising its bid for Genzyme Corp., while Allergan Inc. sees an increase in its shares after the FDA approves its eye inflation drug Ozurdex. Meanwhile, other health care stocks, such as Johnson & Johnson and Pfizer, are experiencing declines.

Key Takeaways:

• The Dow Jones U.S. Health Care Index is down 1.32, or 0.41%, to 317.81.
• Sanofi-Aventis is looking at raising its bid for Genzyme Corp., with shares down 1.53% to $33.50 and Genzyme shares down 0.21% to $71.45.
• Allergan Inc. sees an increase in its shares after the FDA approves its eye inflammation drug Ozurdex, with shares up 0.24% to $66.52.
• Johnson & Johnson is up 0.3% and Pfizer is down 0.9%.
• The Comtex SmarTrend Alert indicated a DOWNTREND on 07-23-2010 for AGN @ $60.78.
• The Comtex SmarTrend Alert indicated an UPTREND on 09-13-2010 for BAC @ $13.97.
• The Comtex SmarTrend Alert indicated a DOWNTREND on 05-05-2010 for C @ $4.15.

Statistics:

• Dow Jones U.S. Health Care Index: -1.32, (-0.41%), to 317.81
• Sanofi-Aventis share price: $33.50, down 1.53%
• Genzyme share price: $71.45, down 0.21%
• Allergan share price: $66.52, up 0.24%
• Johnson & Johnson share price: up 0.3%
• Pfizer share price: down 0.9%
• FDA approvals for Ozurdex: 1

Sources:

• The Wall Street Journal
• MidnightTrader.com
• Comtex News Network, Inc.
• www.mysmartrend.com
• www.comtex.com